Cost-effectiveness of hypofractionated versus conventional fractionated radiotherapy for the treatment of men with early glottic cancer: a study in the Brazilian public and private health system

被引:0
作者
Lourencao, Marina [1 ]
Arruda, Gustavo Viani [2 ]
Rocha, Lucas Penna [3 ]
Galendi, Julia Simoes Correa [4 ,5 ,6 ]
de Oliveira, Jorge Caldeira [1 ]
Jacinto, Alexandre Arthur [7 ]
机构
[1] Univ Sao Paulo, Sch Econ Business Adm & Accounting Ribeirao Preto, Dept Business Adm, Sao Paulo, Brazil
[2] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Radiat Oncol, Sao Paulo, Brazil
[3] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Head & Neck, Sao Paulo, Brazil
[4] Fac Med, Cologne, Germany
[5] Univ Hosp Cologne, Cologne, Germany
[6] Univ Cologne, Inst Hlth Econ & Clin Epidemiol, Cologne, Germany
[7] Barretos Canc Hosp, Dept Radiat Oncol, Sao Paulo, Brazil
关键词
Early glottic cancer; Radiotherapy; Hypofractionation; Conventional fractionation; Cost-effectiveness; INTENSITY-MODULATED RADIOTHERAPY; SQUAMOUS-CELL CARCINOMA; NECK-CANCER; TOXICITY; THERAPY; SIZE; TIME; LIFE; HEAD;
D O I
10.1186/s12913-023-09397-5
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
BackgroundThis study aims to evaluate whether hypofractionated radiotherapy (HYPOFRT) is a cost-effective strategy than conventional fractionated radiotherapy (CFRT) for early-stage glottic cancer (ESGC) in the Brazilian public and private health systems.MethodsAdopting the perspective of the Brazilian public and private health system as the payer, a Markov model with a lifetime horizon was built to delineate the health states for a cohort of 65-year-old men after with ESGC treated with either HYPOFRT or CFRT. Probabilities of controlled disease, local failure, distant metastasis, and death and utilities scores were extracted from randomized clinical trials. Costs were based on the public and private health system reimbursement values.ResultsIn the base case scenario, for both the public and private health systems, HYPOFRT dominated CFRT, being more effective and less costly, with a negative ICER of R$264.32 per quality-adjusted life-year (QALY) (public health system) and a negative ICER of R$2870.69/ QALY (private health system). The ICER was most sensitive to the probability of local failure, controlled disease, and salvage treatment costs. For the probabilistic sensitivity analysis, the cost-effectiveness acceptability curve indicates that there is a probability of 99.99% of HYPOFRT being cost-effective considering a willingness-to-pay threshold of R$2,000 ($905.39) per QALY (public sector) and willingness-to-pay threshold of R$16,000 ($7243.10) per QALY (private sector). The results were robust in deterministic and probabilistic sensitivity analyses.ConclusionsConsidering a threshold of R$ 40,000 per QALY, HYPOFRT was cost-effective compared to CFRT for ESGC in the Brazilian public health system. The Net Monetary Benefit (NMB) is approximately 2,4 times (public health system) and 5,2 (private health system) higher for HYPOFRT than CFRT, which could open the opportunity of incorporating new technologies.
引用
收藏
页数:14
相关论文
共 45 条
  • [1] [Anonymous], COST EFFECTIVENESS A
  • [2] Cost-effectiveness of stereotactic body radiotherapy versus conventional radiotherapy for the treatment of surgically ineligible stage I non-small cell lung cancer in the Brazilian public health system
    Arruda, Gustavo Viani
    Lourencao, Marina
    Caldeira de Oliveira, Jorge Henrique
    Correa Galendi, Julia Simoes
    Jacinto, Alexandre Arthur
    [J]. LANCET REGIONAL HEALTH-AMERICAS, 2022, 14
  • [3] Arruda GV., 2020, BRAZILIAN J ONCOLOGY, V16, P1
  • [4] Cost-Effectiveness of Surgery Versus Organ Preservation in Advanced Laryngeal Cancer
    Beck, Ann-Jean C. C.
    van Harten, Wim H.
    van den Brekel, Michiel W. M.
    Navran, Arash
    Retel, Valesca P.
    [J]. LARYNGOSCOPE, 2021, 131 (02) : E509 - E517
  • [5] CBHPM. AMB, US
  • [6] T1N0 TO T2N0 SQUAMOUS CELL CARCINOMA OF THE GLOTTIC LARYNX TREATED WITH DEFINITIVE RADIOTHERAPY
    Chera, Bhishamjit S.
    Amdur, Robert J.
    Morris, Christopher G.
    Kirwan, Jessica M.
    Mendenhall, William M.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (02): : 461 - 466
  • [7] Carotid sparing intensity modulated radiotherapy on early glottic cancer: preliminary study
    Choi, Hoon Sik
    Jeong, Bae Kwon
    Jeong, Hojin
    Song, Jin Ho
    Kim, Jin Pyeong
    Park, Jung Je
    Woo, Seung Hoon
    Kang, Ki Mun
    [J]. RADIATION ONCOLOGY JOURNAL, 2016, 34 (01): : 26 - 33
  • [8] conitec.gov, US
  • [9] de Arruda F.T., 2017, BRAZ J ONCOL, V13, P1
  • [10] Gender-dependent radiotherapy: The next step in personalised medicine?
    De Courcy, Louis
    Bezak, Eva
    Marcu, Loredana G.
    [J]. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2020, 147